Skip to content

Author

Hamide Nasiri

We have 3 of 40 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

NF-κB across the Alzheimer disease spectrum: Context-dependent protective and pathogenic roles

This review synthesizes the context-dependent roles of NF-κB in AD and provides a framework for reconciling its apparently opposing effects, and argues against indiscriminate activation or global inhibition of NF-κB, either of which could disrupt physiological functions while failing to selectively suppress disease-dri...

A. Azargoonjahromi, F. Abutalebian, Hamide Nasiri · 1 citation
Open access Aug 2026

Plasma p-tau217 as a two-cutoff approach to improve tau-PET screening and trial recruitment in Alzheimer’s disease

Blood-based biomarkers could broaden access to Alzheimer’s disease diagnostics, but their ability to approximate tau PET, and to address gray-zone results, remains uncertain. We evaluated plasma p-tau217 against tau PET using a harmonized ADNI baseline cohort and an independently derived temporal meta-ROI tau-PET thres...

Yasaman Abtahi, Nikki Ghadiminia, Hamide Nasiri et al. · 0 citations
Open access Jul 2026

Diagnostic Performance of the AlzoSure Predict Assay and Its Association With Alzheimer's Disease Biomarkers and Imaging Findings

This work aimed to evaluate the association between U‐p53AZ with established cerebrospinal fluid (CSF) and neuroimaging measures, and to determine its diagnostic performance in distinguishing cognitively normal individuals from those with mild cognitive impairment (MCI).

Ali Rajabpour-Sanati, Hamide Nasiri, F. Khosravi et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.